[Video] Biotech Angel Groups Panel at RESI 4

Featured Posts

• RESI San Diego 2017 Innovation Challenge – Winners Announced

  By Nono Hu, Director of Marketing, LSN On June 19, more than 600 healthcare entrepreneurs and investors entered the exhibition hall at the Westin San Diego Gaslamp Quarter. They were greeted by 30 Innovation Challenge finalists across therapeutics, medical device, diagnostics, and healthcare IT sectors. The 30 companies, hand selected by LSN’s scientific and commercial review team, […]

• Hot Investor Mandate 1: Family Office Investing in Personal Medicine Diagnostics and Digital Health

  A private investment firm led by seasoned entrepreneur and venture capitalist is looking to make venture investments in emerging fast growth projects. Typical equity investments ranges from $500,000 to $3 million per deal. The firm will invest in companies across the United States and Canada. Currently the firm is most interested in areas of personal […]

• Hot Investor Mandate 2: European-based Evergreen Fund Investing in Early-stage Therapeutics

  An evergreen life science venture fund located in Copenhagen, Denmark, established in the autumn of 2009 and wholly owned by a large European corporate currently has DKK 1.6 billion in AUM. The firm has an annual investment capacity of approximately 350 – 400m DKK. Investments are typically around €10 million with reserves to follow, and […]

• Hot Investor Mandate 3: Taiwan-based CVC Investing in Therapeutics and Digital Health

  A corporate venture of a publicly listed Taiwanese pharmaceutical company now focuses on strategic investments and add-on acquisition for its portfolio companies. Typical allocation size ranges from US$5-20 million. The firm is currently seeking opportunities in Asia and the US. The CVC is investing strategically for its portfolio companies in select sectors. Within therapeutics, the […]

• Hot Investor Mandate 4: Subsidiary Fund of Health Insurance Corporate Investing in Consumer Health Solutions

  A wholly owned subsidiary of an established private health insurance company seeks to investment in technologies that are a strategic fit with members of the network. The firm is flexible in terms of investment sizes and considers an array of capital structures including equity, convertible note, debt, and others. The firm typically co-invests with other […]